Selected research
Market Analysis & Forecast
Global Valsartan Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Valsartan Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Valsartan Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Valsartan Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Valsartan Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Valsartan Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Valsartan Tablets include Alembic, Aurobindo, Cadista, Camber, Lupin, Major, Repackagers, Solco Healthcare and Changzhou Siyao Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Valsartan Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Valsartan Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valsartan Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valsartan Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valsartan Tablets sales, projected growth trends, production technology, application and end-user industry.
Valsartan Tablets Segment by Company
Alembic
Aurobindo
Cadista
Camber
Lupin
Major
Repackagers
Solco Healthcare
Changzhou Siyao Pharmaceutical
Mylan
Teva
Zhejiang Huahai Pharm
Valsartan Tablets Segment by Type
80mg
40mg
320mg
160mg
Valsartan Tablets Segment by Application
Clinic
Hospital
Recovery Center
Valsartan Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Valsartan Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 80mg
- 40mg
- 320mg
- 160mg
Applications
- Clinic
- Hospital
- Recovery Center
Companies covered
- Alembic
- Aurobindo
- Cadista
- Camber
- Lupin
- Major
- Repackagers
- Solco Healthcare
- Changzhou Siyao Pharmaceutical
- Mylan
- Teva
- Zhejiang Huahai Pharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Valsartan Tablets Market by Type
- 1.2.1 Global Valsartan Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 80mg
- 1.2.3 40mg
- 1.2.4 320mg
- 1.2.5 160mg
- 1.3 Valsartan Tablets Market by Application
- 1.3.1 Global Valsartan Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Recovery Center
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Valsartan Tablets Market Dynamics
- 2.1 Valsartan Tablets Industry Trends
- 2.2 Valsartan Tablets Industry Drivers
- 2.3 Valsartan Tablets Industry Opportunities and Challenges
- 2.4 Valsartan Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Valsartan Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Valsartan Tablets Revenue by Region
- 3.2.1 Global Valsartan Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Valsartan Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Valsartan Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Valsartan Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Valsartan Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Valsartan Tablets Sales by Region
- 3.4.1 Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Valsartan Tablets Sales by Region (2021-2026)
- 3.4.3 Global Valsartan Tablets Sales by Region (2027-2032)
- 3.4.4 Global Valsartan Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Valsartan Tablets Revenue by Manufacturers
- 4.1.1 Global Valsartan Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Valsartan Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Valsartan Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Valsartan Tablets Sales by Manufacturers
- 4.2.1 Global Valsartan Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Valsartan Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Valsartan Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Valsartan Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Valsartan Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Valsartan Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Valsartan Tablets Manufacturers, Product Type & Application
- 4.7 Global Valsartan Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Valsartan Tablets Market CR5 and HHI
- 4.8.2 2025 Valsartan Tablets Tier 1, Tier 2, and Tier 3
5 Valsartan Tablets Market by Type
- 5.1 Global Valsartan Tablets Revenue by Type
- 5.1.1 Global Valsartan Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Valsartan Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Valsartan Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Valsartan Tablets Sales by Type
- 5.2.1 Global Valsartan Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Valsartan Tablets Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Valsartan Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Valsartan Tablets Price by Type
6 Valsartan Tablets Market by Application
- 6.1 Global Valsartan Tablets Revenue by Application
- 6.1.1 Global Valsartan Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Valsartan Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Valsartan Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Valsartan Tablets Sales by Application
- 6.2.1 Global Valsartan Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Valsartan Tablets Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Valsartan Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Valsartan Tablets Price by Application
7 Company Profiles
- 7.1 Alembic
- 7.1.1 Alembic Company Information
- 7.1.2 Alembic Business Overview
- 7.1.3 Alembic Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Alembic Valsartan Tablets Product Portfolio
- 7.1.5 Alembic Recent Developments
- 7.2 Aurobindo
- 7.2.1 Aurobindo Company Information
- 7.2.2 Aurobindo Business Overview
- 7.2.3 Aurobindo Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Aurobindo Valsartan Tablets Product Portfolio
- 7.2.5 Aurobindo Recent Developments
- 7.3 Cadista
- 7.3.1 Cadista Company Information
- 7.3.2 Cadista Business Overview
- 7.3.3 Cadista Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Cadista Valsartan Tablets Product Portfolio
- 7.3.5 Cadista Recent Developments
- 7.4 Camber
- 7.4.1 Camber Company Information
- 7.4.2 Camber Business Overview
- 7.4.3 Camber Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Camber Valsartan Tablets Product Portfolio
- 7.4.5 Camber Recent Developments
- 7.5 Lupin
- 7.5.1 Lupin Company Information
- 7.5.2 Lupin Business Overview
- 7.5.3 Lupin Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lupin Valsartan Tablets Product Portfolio
- 7.5.5 Lupin Recent Developments
- 7.6 Major
- 7.6.1 Major Company Information
- 7.6.2 Major Business Overview
- 7.6.3 Major Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Major Valsartan Tablets Product Portfolio
- 7.6.5 Major Recent Developments
- 7.7 Repackagers
- 7.7.1 Repackagers Company Information
- 7.7.2 Repackagers Business Overview
- 7.7.3 Repackagers Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Repackagers Valsartan Tablets Product Portfolio
- 7.7.5 Repackagers Recent Developments
- 7.8 Solco Healthcare
- 7.8.1 Solco Healthcare Company Information
- 7.8.2 Solco Healthcare Business Overview
- 7.8.3 Solco Healthcare Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Solco Healthcare Valsartan Tablets Product Portfolio
- 7.8.5 Solco Healthcare Recent Developments
- 7.9 Changzhou Siyao Pharmaceutical
- 7.9.1 Changzhou Siyao Pharmaceutical Company Information
- 7.9.2 Changzhou Siyao Pharmaceutical Business Overview
- 7.9.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio
- 7.9.5 Changzhou Siyao Pharmaceutical Recent Developments
- 7.10 Mylan
- 7.10.1 Mylan Company Information
- 7.10.2 Mylan Business Overview
- 7.10.3 Mylan Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Mylan Valsartan Tablets Product Portfolio
- 7.10.5 Mylan Recent Developments
- 7.11 Teva
- 7.11.1 Teva Company Information
- 7.11.2 Teva Business Overview
- 7.11.3 Teva Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Teva Valsartan Tablets Product Portfolio
- 7.11.5 Teva Recent Developments
- 7.12 Zhejiang Huahai Pharm
- 7.12.1 Zhejiang Huahai Pharm Company Information
- 7.12.2 Zhejiang Huahai Pharm Business Overview
- 7.12.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio
- 7.12.5 Zhejiang Huahai Pharm Recent Developments
8 North America
- 8.1 North America Valsartan Tablets Market Size by Type
- 8.1.1 North America Valsartan Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Valsartan Tablets Sales by Type (2021-2032)
- 8.1.3 North America Valsartan Tablets Price by Type (2021-2032)
- 8.2 North America Valsartan Tablets Market Size by Application
- 8.2.1 North America Valsartan Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Valsartan Tablets Sales by Application (2021-2032)
- 8.2.3 North America Valsartan Tablets Price by Application (2021-2032)
- 8.3 North America Valsartan Tablets Market Size by Country
- 8.3.1 North America Valsartan Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Valsartan Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Valsartan Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Valsartan Tablets Market Size by Type
- 9.1.1 Europe Valsartan Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Valsartan Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Valsartan Tablets Price by Type (2021-2032)
- 9.2 Europe Valsartan Tablets Market Size by Application
- 9.2.1 Europe Valsartan Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Valsartan Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Valsartan Tablets Price by Application (2021-2032)
- 9.3 Europe Valsartan Tablets Market Size by Country
- 9.3.1 Europe Valsartan Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Valsartan Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Valsartan Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Valsartan Tablets Market Size by Type
- 10.1.1 China Valsartan Tablets Revenue by Type (2021-2032)
- 10.1.2 China Valsartan Tablets Sales by Type (2021-2032)
- 10.1.3 China Valsartan Tablets Price by Type (2021-2032)
- 10.2 China Valsartan Tablets Market Size by Application
- 10.2.1 China Valsartan Tablets Revenue by Application (2021-2032)
- 10.2.2 China Valsartan Tablets Sales by Application (2021-2032)
- 10.2.3 China Valsartan Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Valsartan Tablets Market Size by Type
- 11.1.1 Asia Valsartan Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Valsartan Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Valsartan Tablets Price by Type (2021-2032)
- 11.2 Asia Valsartan Tablets Market Size by Application
- 11.2.1 Asia Valsartan Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Valsartan Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Valsartan Tablets Price by Application (2021-2032)
- 11.3 Asia Valsartan Tablets Market Size by Country
- 11.3.1 Asia Valsartan Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Valsartan Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Valsartan Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Valsartan Tablets Market Size by Type
- 12.1.1 SAMEA Valsartan Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Valsartan Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Valsartan Tablets Price by Type (2021-2032)
- 12.2 SAMEA Valsartan Tablets Market Size by Application
- 12.2.1 SAMEA Valsartan Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Valsartan Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Valsartan Tablets Price by Application (2021-2032)
- 12.3 SAMEA Valsartan Tablets Market Size by Country
- 12.3.1 SAMEA Valsartan Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Valsartan Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Valsartan Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Valsartan Tablets Value Chain Analysis
- 13.1.1 Valsartan Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Valsartan Tablets Production Mode & Process
- 13.2 Valsartan Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Valsartan Tablets Distributors
- 13.2.3 Valsartan Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst